Please visit our MS learning channel on Youtube, which provides hundreds of topics from our education programs, that were video-recorded and archived here: www.youtube.com/msviewsandnews -- Be empowered with MS news by registering with us: www.register.msviewsandnews.org

joomla ecommerce template -- Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

============================================================

Friday, October 2, 2015

MS One to One Presents - Informative MS educational programs

Trouble viewing? View as a Web page
Do not take AUBAGIO if you have severe liver problems, are pregnant or are of childbearing potential and not using effective birth control, or are taking a medication called leflunomide.
View IMPORTANT SAFETY INFORMATION
Please click here for full Prescribing Information, including boxed WARNING, and Medication Guide.
The topic is close to you.
Our events are, too.
Hello,
Just taking some time to listen and ask questions can be a great way to learn something new. So we host a variety of informative events where you can get answers about relapsing forms of multiple sclerosis (MS) and AUBAGIO® (teriflunomide). You'll hear from experts and people living with MS, plus hear about a once-a-day pill for MS. As part of your participation at a live event, a meal may be provided.
Events coming up in your area.
Show me
Have a question about MS or an event?
Talk to an MS One to One® Nurse 24/7 at 1-855-676-6326.
Call
Please scroll down for Important Safety Information.
AUBAGIO® (teriflunomide) is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS).
IMPORTANT SAFETY INFORMATION
DO NOT TAKE AUBAGIO IF YOU:
Have severe liver problems. AUBAGIO may cause serious liver problems, which can be life-threatening. Your risk may be higher if you take other medicines that affect your liver. Your healthcare provider should do blood tests to check your liver within 6 months before you start AUBAGIO and monthly for 6 months after starting AUBAGIO. Tell your healthcare provider right away if you develop any of these symptoms of liver problems: nausea, vomiting, stomach pain, loss of appetite, tiredness, yellowing of your skin or whites of your eyes, or dark urine.
Take a medicine called leflunomide for rheumatoid arthritis.
Are pregnant. AUBAGIO may harm an unborn baby. You should have a pregnancy test before starting AUBAGIO. After stopping AUBAGIO, continue to use effective birth control until you have made sure your blood levels of AUBAGIO are lowered. If you become pregnant while taking AUBAGIO or within 2 years after stopping, tell your healthcare provider right away and enroll in the AUBAGIO Pregnancy Registry at 1‑800‑745‑4447, option 2.
Are of childbearing potential and not using effective birth control.
It is not known if AUBAGIO passes into breast milk. Your healthcare provider can help you decide if you should take AUBAGIO or breastfeed — you should not do both at the same time.
If you are a man whose partner plans to become pregnant, you should stop taking AUBAGIO and talk with your healthcare provider about reducing the levels of AUBAGIO in your blood. If your partner does not plan to become pregnant, use effective birth control while taking AUBAGIO.
AUBAGIO may stay in your blood for up to 2 years after you stop taking it. Your healthcare provider can prescribe a medicine that can remove AUBAGIO from your blood quickly.
Before taking AUBAGIO, talk with your healthcare provider if you have: liver or kidney problems; a fever or infection, or if you are unable to fight infections; numbness or tingling in your hands or feet that is different from your MS symptoms; diabetes; serious skin problems when taking other medicines; breathing problems; or high blood pressure. Your healthcare provider will check your blood cell count and TB test before you start AUBAGIO. Talk with your healthcare provider if you take or are planning to take other medicines (especially medicines for treating cancer or controlling your immune system), vaccines, vitamins or herbal supplements.
AUBAGIO may cause serious side effects, including: reduced white blood cell count — this may cause you to have more infections; numbness or tingling in your hands or feet that is different from your MS symptoms; serious skin problems; breathing problems (new or worsening); and high blood pressure.
The most common side effects when taking AUBAGIO include: headache; diarrhea; nausea; hair thinning or loss; and abnormal liver test results. These are not all the side effects of AUBAGIO. Tell your healthcare provider about any side effect that bothers you.
Consult your healthcare provider if you have questions about your health or any medications you may be taking, including AUBAGIO.
Please click here for full Prescribing Information, including boxed WARNING, and Medication Guide.
You are encouraged to report side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088.
Please DO NOT REPLY TO THIS EMAIL. Genzyme will not receive this message if you reply. If you have any questions regarding this email or Genzyme, click here.
To unsubscribe from our mailing list, please click here.
Copyright © 2015 Genzyme Corporation, a Sanofi company. All rights reserved. AUBAGIO and Genzyme are registered trademarks of Genzyme Corporation.
Intended for US residents only.
GZUS.AUBA.15.03.0718 Last Update: March 2015
GZUS.AUBA.15.03.0718
Last Update: March 2015


~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

.===================================

No comments: